Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?
- Chris Skedgel
- , Daniel Rayson
- , Tallal Younis
Research output: Contribution to journal › Article › peer-review
9
Link opens in a new tab
Citations
(Scopus)